Akers Biosciences, Inc. (NASDAQ:AKER) (AIM:AKR.L), ("Akers Bio" or
the "Company"), a medical device company focused on reducing the
cost of healthcare through faster, easier diagnostics, announces
that sales of the Company's consumer-focused METRON® Breath Ketone
Test - the first and only disposable breath ketone test - have
commenced through the Amazon Marketplace and via the Company's
online sales portal www.metron.akersbio.com. This marks the first
of a number of channels through which the Company intends to
commercialize its transformative line of health and wellness
products based on its proprietary MPC® Biosensor technology for
evaluating exhaled breath.
The METRON® Breath Ketone Test, part of the Akers Wellness line,
is the only disposable breath-based diagnostic device that rapidly
determines if the subject is in ketosis. Ketosis is a fat-burning
state where the body breaks down body fat for energy. Not only is
ketosis a desirable state for the millions of people interested in
weight loss, it is also important to fitness enthusiasts as a means
of monitoring an efficient metabolism for training and sporting
events. Studies have also suggested that it is beneficial for many
other health-related concerns.
Ketosis can be affected by several factors, thus it is important
to evaluate your ketogenic state regularly if fat loss or a fat
burning metabolism is your goal. While there are competitive tests
currently available, each has significant drawbacks which hinder
their effectiveness. For example, although urinary dipstick ketone
tests are inexpensive, the results of these tests are not
necessarily related to physiological levels of ketones, and may not
even be indicative of the presence or absence of ketosis over time.
Additionally, many people may find both the urine and blood testing
processes to be unpleasant. In contrast, the METRON® Breath Ketone
Test is simple and convenient, and provides accurate analysis of
ketones, even over time.
"Quite simply, we believe METRON® is a better way to test for
ketosis," said Raymond F. Akers, Jr. PhD, Co-founder and Executive
Chairman. "With the METRON® Breath Ketone Test, you no longer need
invasive blood draws or inconvenient urine tests – you just breathe
into the device and get a highly accurate reading in less than
three minutes," continued Dr. Akers. "We think this is going to
make a huge difference to people trying to lose weight, those
trying to maximize their fitness training, or other people who just
want to maintain a healthier body. I'm extremely excited that
consumers can now buy this product, and we are proud to provide an
innovative solution that can help people live healthier lives,"
added Dr. Akers.
"METRON® has received a significant amount of interest from
consumers, fitness professionals, and health and wellness
consultants since we announced our intention to launch the product.
In fact, it was the extent of this demand that led us to offer this
product through Amazon and our own online sales portal
(www.metron.akersbio.com). We've launched initially in America but
plan to make METRON® available to consumers worldwide. This launch
is a significant event for our company as METRON® forms a
cornerstone of our strategy to build shareholder value through our
presence in the substantial health and wellness industry," said Dr.
Akers.
ABOUT AKERS BIOSCIENCES, INC.
Akers Biosciences develops, manufactures, and supplies rapid
screening and testing products designed to deliver quicker and more
cost-effective healthcare information to healthcare providers and
consumers. The Company has advanced the science of diagnostics
while responding to major shifts in healthcare through the
development of several proprietary platform technologies. The
Company's state-of-the-art rapid diagnostic assays can be performed
virtually anywhere in minutes when time is of the essence. The
Company has aligned with major healthcare companies and high volume
medical product distributors to maximize product offerings, and to
be a major worldwide competitor in diagnostics.
Additional information on the Company and its products can be
found at www.akersbio.com. Follow us on Twitter @AkersBio.
ABOUT AKERS WELLNESS
As big data and personalized health information revolutionize
health management, the focus is shifting to prevention – rather
than treatment – of disease states. Akers Wellness exists to bring
innovative diagnostic tests to market that provide near-instant
health information to professionals and consumers so that they can
make better decisions to manage health lifestyle
choices. Akers Wellness' current portfolio focuses on
convenient and easy-to-use breath tests, coupled with mobile
technology to enable users to access and track their health
information wherever they go!
Akers Wellness brings Innovation for Health…One Breath at a
Time.
ABOUT METRON®
The METRON® Breath Ketone Test is a rapid and convenient way to
accurately measure ketones to determine if you are in a state of
nutritional ketosis, or "fat-burning".
METRON® does not require blood draws or inconvenient urine
samples, just your breath! And since breath acetone is highly
correlated with the ketones in your blood, the test provides an
accurate determination of whether you are in ketosis.
- METRON® Breath Ketone Test is the first and only disposable
breath test for ketosis
- Takes less than 3 minutes!
- Highly accurate – correlates well to the benchmark blood-based
ketone testing
- Facilitates frequent testing to monitor if you are currently in
a fat-burning ketogenic state
- Results shown with an easy-to-read color change
- Uses patented MPC™ Biosensor technology
- Small, hand-held disposable design (only 5 1/4" long) – test
anywhere!
ABOUT KETOSIS
Ketosis is a metabolic state where the body utilizes fat stores
for energy, in contrast to a state of glycolysis, where blood
glucose provides energy. Most people in the developed world
are regularly in a state of glycolysis.
However, when blood glucose from carbohydrates and simple sugar
sources cannot meet cellular energy demands, the body forms ketone
bodies from fat tissue and subsequently utilizes these ketone
bodies for energy. This is considered being in a ketogenic state or
in a state of ketosis, commonly referred to as "fat burning".
Ketosis is a desirable state for many people interested in
weight-loss, specifically loss of body fat. Ketosis is also of
interest to diabetics for blood sugar control and has shown
therapeutic evidence for many other health-related concerns. A
ketogenic state can be achieved through dramatically reduced
carbohydrate intake and exercise.
Cautionary Statement Regarding Forward Looking
Statements
Statements contained herein that are not based upon current or
historical fact are forward-looking in nature and constitute
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934. Such forward-looking statements reflect the Company's
expectations about its future operating results, performance and
opportunities that involve substantial risks and uncertainties.
These statements include but are not limited to statements
regarding the intended terms of the offering, closing of the
offering and use of any proceeds from the offering. When used
herein, the words "anticipate," "believe," "estimate," "upcoming,"
"plan," "target", "intend" and "expect" and similar expressions, as
they relate to Akers Biosciences, Inc., its subsidiaries, or its
management, are intended to identify such forward-looking
statements. These forward-looking statements are based on
information currently available to the Company and are subject to a
number of risks, uncertainties, and other factors that could cause
the Company's actual results, performance, prospects, and
opportunities to differ materially from those expressed in, or
implied by, these forward-looking statements.
CONTACT: For more information:
Akers Biosciences, Inc.
Raymond F. Akers, Jr. PhD
Executive Chairman of the Board
Tel. +1 856 848 8698
finnCap (UK Nominated Adviser and Broker)
Geoff Nash / Scott Mathieson (Corporate Finance)
Steve Norcross (Broking)
Tel. +44 (0)20 7220 0500
Taglich Brothers, Inc. (Investor Relations)
Chris Schreiber
Tel. +1 917 445 6207
Vigo Communications (Public Relations)
Ben Simons / Fiona Henson
Tel. +44 (0)20 7016 9570
Email: akers@vigocomms.com
Akers Biosciences (LSE:AKR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Akers Biosciences (LSE:AKR)
Historical Stock Chart
From Apr 2023 to Apr 2024